Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03015480 · ClinicalTrials.gov registry record · NA
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
A NA study of Diabetes Mellitus and Chronic Kidney Disease, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT03015480: Completed NA study of Diabetes Mellitus and Chronic Kidney Disease, sponsored by Geisinger Clinic.
NCT03015480 is a NA study of Diabetes Mellitus and Chronic Kidney Disease that has completed, run by Geisinger Clinic. The registered enrollment target is 50 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03015480, a NA study of Diabetes Mellitus and Chronic Kidney Disease, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
This pilot study tests the feasibility of dietary app-supported tele-counseling in the treatment of patients with stage 1-3a chronic kidney disease (CKD) and diabetes.
Primary Outcome
unadjusted and adjusted for creatinine excretion
Conditions Studied
Interventions
- BEHAVIORAL Remote counseling
Study Locations (2)
Pennsylvania
- Geisinger Medical Center - Danville
- Geisinger Wyoming Valley Medical Center - Wilkes-Barre
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-02-13 |
| Est. Completion | 2018-11-25 |
| Phase | NA |
What the finished NCT03015480 record still lists
NCT03015480 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Remote counseling is the first listed.
NCT03015480 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03015480 about?
NCT03015480 is a clinical study titled "Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes". This pilot study tests the feasibility of dietary app-supported tele-counseling in the treatment of patients with stage 1-3a chronic kidney disease (CKD) and diabetes.
What is the current status of trial NCT03015480?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-02-13. Estimated completion is 2018-11-25.
What conditions does trial NCT03015480 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Chronic Kidney Disease, Albuminuria.
What interventions are being tested in trial NCT03015480?
The interventions under investigation include: Remote counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT03015480?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03015480 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03015480's enrollment target sits among peer trials
50 151st of 208 higher than 55 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI